跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/EUCTR2006-000858-45-SE
EUCTR2006-000858-45-SE进行中（未招募）不适用

An open label SLV308 safety extension to study S308.3.001 in early PD patients. - An extension of the Rembrandt study

Solvay Pharmaceuticals0 个研究点目标入组 300 人开始时间: 2007年4月4日最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
适应症

试验速览

阶段
不适用
状态
进行中（未招募）
入组人数
300
研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • •- Subjects who have signed informed consent for participation in the extension study.
  • •- Subjects who have completed the S308.3.001 trial.
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1.2 Adults (18-64 years) yes
  • •F.1.2.1 Number of subjects for this age range
  • •F.1.3 Elderly (>=65 years) yes
  • •F.1.3.1 Number of subjects for this age range

排除标准

  • •- Subjects with medically relevant abnormal findings (ECG, physical examination, AEs) at end of the maintenance phase (Visit M6, Week 24) of study S308.3.001.

研究者

相似试验

进行中（未招募）
不适用
An open label SLV308 safety extension to study S308.3.002 in patients with Parkinson’s disease experiencing motor fluctuations. - An extension of the Mondrian studyAdvanced stage Parkinson's disease with motor fluctuations.MedDRA version: 9.1Level: LLTClassification code 10013113Term: Disease Parkinson's
EUCTR2006-005183-91-LTSolvay Pharmaceuticals220
进行中（未招募）
不适用
An open label SLV308 safety extension to study S308.3.003 in early PD patients - An extension to the Vermeer studyParkinson's Disease Early stage
EUCTR2006-000859-18-CZSolvay Pharmaceuticals225
进行中（未招募）
1 期
An open label SLV308 safety extension to study S308.3.001 in early PD patients. - An extension of the Rembrandt studyParkinson's Disease Early Stage
EUCTR2006-000858-45-SKSolvay Pharmaceuticals300
进行中（未招募）
不适用
An open label SLV308 safety extension to study S308.3.003 in early PD patients - An extension to the Vermeer studyParkinson's Disease Early stage
EUCTR2006-000859-18-NLSolvay pharmaceuticals247
进行中（未招募）
不适用
An open label SLV308 safety extension to study S308.3.003 in early PD patients - An extension to the Vermeer studyParkinson's Disease Early stage
EUCTR2006-000859-18-DESolvay pharmaceuticals225